Levothyroxine treatment in pregnant women with thyroid stimulating hormone levels ranging between 2.5 and 10 mIU/L: A propensity score matched analysis

CONCLUSION: LT-4 treatment was significantly associated with a lower risk of pregnancy loss and a higher risk of small-for-gestational-age infants in pregnant women with TSH levels of 2.5-10 mIU/L. An increased risk of preterm birth was observed in the LT-4-treated group among TPOAb-positive participants with TSH levels of 2.5-4.0 mIU/L.PMID:38666684 | DOI:10.1089/thy.2023.0662

Source: Thyroid : official journal of the American Thyroid Association - April 26, 2024 Category: Endocrinology Authors: Shen Gao Xueran Wang Rong Zhao Yuchen Cui Shaofei Su Enjie Zhang Jianhui Liu Shuanghua Xie Yue Zhang Yuxi Yang Kaikun Huang Minhui Hu Wentao Yue Ruixia Liu Chenghong Yin Source Type: research